Home › Funds › VILLERE ST DENIS J & CO LLC › ABT

VILLERE ST DENIS J & CO LLC position in ABT

ABBOTT LABORATORIES · Health Care

VILLERE ST DENIS J & CO LLC reported holding 180,259 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$17.8M, representing 2.30% of its reported portfolio and ranking #18 among its reported holdings. VILLERE ST DENIS J & CO LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)180.26K sh
Reported value held$17.81M
Portfolio Weight2.30%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How VILLERE ST DENIS J & CO LLC's ABT position evolved

VILLERE ST DENIS J & CO LLC first disclosed a stake in ABT in Q3 2023 at 199,110 shares (US$19.3M). The position peaked in Q2 2025 at 239,301 shares, worth US$32.5M. Across 13 filings, VILLERE ST DENIS J & CO LLC increased the stake 2 time(s), trimmed it 8 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 180,259 shares valued at US$17.8M — a reduction of -28,565 shares quarter over quarter.. Notable position changes include a 42% increase in Q1 2024 (shares fell 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 199.11K $19.28M New
Q4 2023 180.49K $19.87M Reduce
Q1 2024 256.31K $29.13M Add
Q2 2024 256.32K $26.63M Hold
Q3 2024 251.71K $28.70M Reduce
Q4 2024 242.25K $27.40M Reduce
Q1 2025 244.52K $32.44M Add
Q2 2025 239.30K $32.55M Reduce
Q3 2025 235.82K $31.59M Reduce
Q4 2025 231.39K $28.99M Reduce
Q1 2026 230.46K $23.66M Hold
Q2 2026 208.82K $18.95M Reduce
Q3 2026 180.26K $17.81M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has VILLERE ST DENIS J & CO LLC held ABT?

VILLERE ST DENIS J & CO LLC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is VILLERE ST DENIS J & CO LLC's current position in ABT?

As of Q3 2026, VILLERE ST DENIS J & CO LLC holds 180.26K shares of ABT (ABBOTT LABORATORIES), valued at $17.81M, representing 2.30% of its reported portfolio and ranking #18.

Has VILLERE ST DENIS J & CO LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), VILLERE ST DENIS J & CO LLC reduced its position in ABT. The position peaked in Q2 2025 at 239.30K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.